An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Part of paid clinical trials in Daphne, Alabama.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT03704077
- Phase
- PHASE2
- Status
- Withdrawn
Conditions
- Cancer of the Stomach
- Gastric Cancer
- Gastroesophageal Junction
- Stomach Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Relatlimab + Nivolumab — BIOLOGICALSpecified dose on specified days
- Nivolumab — BIOLOGICALSpecified dose on specified days
- Paclitaxel — DRUGSpecified dose on specified days
- Ramucirumab — DRUGSpecified dose on specified days
Study Details
The purpose of this study is to determine the effectiveness of relatlimab plus nivolumab, alone or in combination with various standard-of-care treatments in participants with gastric cancer (GC) or gastroesophageal junction (GEJ) adenocarcinoma that has come back or spread to other places in the body after prior therapy.
Key Dates
- Start date
- Oct 31, 2019
- Status verified
- May 2020
- Primary completion
- Feb 27, 2022
- Completion
- Sep 30, 2024
Study Design
- Enrollment
- 0 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Cohort A: relatlimab + nivolumab + paclitaxel
- Experimental: Cohort A: nivolumab + paclitaxel
- Active Comparator: Cohort A: ramucirumab + paclitaxelStandard-of-care
- Experimental: Cohort B: relatlimab + nivolumab
- Active Comparator: Cohort B: nivolumabStandard-of-care
- Experimental: Cohort C: relatlimab + nivolumab
Primary Outcome Measure
Overall response rate (ORR) [ Time Frame: Approximately 31 months ]
Locations (20)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Local Institution | Daphne | Alabama | 36526 | - |
| Local Institution | Bakersfield | California | 93309 | - |
| Local Institution | Fullerton | California | 92835 | - |
| Local Institution | Los Angeles | California | 90095 | - |
| Local Institution | Redondo Beach | California | 90277 | - |
| Local Institution | Santa Barbara | California | 93105 | - |
| Local Institution | Aurora | Colorado | 80045 | - |
| Local Institution | Lakewood | Colorado | 80228 | - |
| Local Institution | Miami | Florida | 33176 | - |
| Local Institution | Tampa | Florida | 33612 | - |
| Local Institution | Marietta | Georgia | 30060 | - |
| Local Institution | Boston | Massachusetts | 02215 | - |
| Local Institution | St Louis | Missouri | 63110 | - |
| Local Institution | New Brunswick | New Jersey | 08009 | - |
| Local Institution | Chapel Hill | North Carolina | 27599 | - |
| Local Institution | Charlotte | North Carolina | 28204 | - |
| Local Institution | Fargo | North Dakota | 58102 | - |
| Local Institution | Allentown | Pennsylvania | 18103 | - |
| Local Institution | Sioux Falls | South Dakota | 57104 | - |
| Local Institution | Vancouver | Washington | 98684 | - |
Find similar trials in Daphne, AL
By condition
By specialty
Related Studies
- Clinical & Pathological Studies of Upper Gastrointestinal CarcinomaRecruiting · Stanford University · Stanford, California
- The Gastric Cancer Foundation: A Gastric Cancer RegistryRecruiting · Stanford University · Stanford, California
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Feasibility of the LUM Imaging System for Detection of Gastrointestinal CancersPHASE1/PHASE2 · Recruiting · Lumicell, Inc. · Boston, Massachusetts